Press Releases

DaVita Inc. (NYSE: DVA) today announced that its chief financial officer, Joel Ackerman, will participate in a fireside chat with investors at the Bank of America Securities 2022 Healthcare...

DaVita Inc. (NYSE: DVA) announced financial and operating results for the quarter ended March 31, 2022. For the quarter, diluted earnings per share was $1.61, a decrease of (10.1)% from the prior...

Today, DaVita Inc. highlighted its continued commitment to corporate citizenship with the publication of its annual Community Care Environmental Social Governance (ESG) Report. "I'm humbled...

DaVita Inc. (NYSE: DVA), announced today that it will hold its quarterly conference call to discuss first quarter results on Thursday, May 5, 2022, at 5 p.m. Eastern Time. The company plans to...

DaVita Inc. announced today that its board of directors appointed a new independent director, Jason M. Hollar, to join the board, effective May 6, 2022. Mr. Hollar brings more than 25 years of...

Results demonstrate the importance of vaccinating patients at trusted sites of care DENVER and WALTHAM, Mass., April 4, 2022 /PRNewswire/ -- A federal partnership established to help increase...

Dialysis patients who received an adenovirus vector-based COVID-19 vaccine (Johnson & Johnson) were found to have similar rates of breakthrough infection, hospitalization and mortality as dialysis...

DaVita Kidney Care today announced Dr. Mihran Naljayan as chief medical officer (CMO) of Home Modalities. Dr. Naljayan joined DaVita in 2016 and most recently served as vice president of clinical...

In honor of National Donor Day—and every living organ donor—DaVita announced it increased paid leave for organ donation to four consecutive weeks for benefits-eligible teammates (employees)...

DaVita Inc. (NYSE: DVA) announced financial and operating results for the quarter and year ended December 31, 2021. "COVID continues to evolve and have a direct impact on our world, especially on...